Lincoln National Corp’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Lincoln National Corp’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-41,070	Closed	-$29.5K	–	1195
2024 Q1	$29.5K	Hold	41,070	–	–	﹤0.01%	1193
2023 Q4	$34.9K	Hold	41,070	–	–	﹤0.01%	1092
2023 Q3	$56.3K	Hold	41,070	–	–	﹤0.01%	1009
2023 Q2	$103K	Hold	41,070	–	–	﹤0.01%	989
2023 Q1	$93.2K	Buy	+41,070	New	+$104K	﹤0.01%	958

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Lincoln National Corp's VAXX Position: Q2 2024 in Review

Lincoln National Corp sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 41,070 shares — an estimated $29.5K sold.

Lincoln National Corp first reported a position in VAXX in Q1 2023 and held it in 5 quarters. The position peaked at $103K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Lincoln National Corp reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Lincoln National Corp sold 41,070 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $29.5K.
Lincoln National Corp first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 5 quarters.
Lincoln National Corp's Vaxxinity, Inc. Class A Common Stock position peaked at $103K in Q2 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.